IBA to install cyclotron in Poland
Proton therapy developer Ion Beam Application (IBA) will install a Cyclone 30XP in Poland for the production of astatine-211 (At-211) for oncology applications. At-211 is an alpha particle emitter used in oncology for targeted therapies to treat brain, thyroid, ovarian, breast, and prostate cancer. This is the company’s third installation in Europe for A-211 production, following earlier installations in Germany and France. Beyond At-211, the company is also developing accelerator applications for other theranostic isotopes, IBA said.
Source: AuntMinnie.com Headlines - Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | France Health | Germany Health | Neurology | Ovarian Cancer | Ovaries | Poland Health | Prostate Cancer | Proton Therapy | Radiology | Thyroid | Thyroid Cancer